₹ 48.45
0.00 (0.00%)
BSE
O
Oxygenta Pharmaceutical
₹ 48.45
BSE
OXYGENTAPH Financials Summary
Oxygenta Pharmaceutical revenue decreased 25.70% quarter-on-quarter to ₹37 Cr in Jun 2026, while net loss widened to ₹2 Cr from ₹2 Cr in the previous quarter. Compared to the same quarter last year, revenue is up 141.83% and net loss narrowed to ₹2 Cr from ₹6 Cr a year ago. EPS for the quarter stood at -₹0.57, decreased from -₹0.45 in the previous quarter and up from -₹1.65 a year ago.
Oxygenta Pharmaceutical Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of OXYGENTAPH Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
OXYGENTAPH Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






